<DOC>
	<DOC>NCT01128530</DOC>
	<brief_summary>The purpose of this study is to determine the clinical efficacy, safety, and tolerability of a 250 mg BID oral dose of JNJ-32729463 compared with linezolid in subjects with complicated skin and skin structure infections (cSSSIs).</brief_summary>
	<brief_title>Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Clinical diagnosis of a complicated skin and skin structure infection (cSSSI) including wound infection, deep cellulitis or severe abscess Women of childbearing potential must agree to use an acceptable form of contraception Infection site offers ability to obtain a microbiological specimen Received only 1 dose of any potentially effective systemic antibiotic within 24 hours of beginning study treatment History of hypersensitivity or allergic reaction to quinolones or to linezolid Female and pregnant or breastfeeding or may be pregnant Chronic or underlying skin condition surrounding the area of infection that may complicate the assessment of response (e.g. atopic dermatitis, eczema, or psoriasis) Subject has infections with a high cure rate after surgical incision alone after aggressive local skin care Subject has infection(s) suspected to be caused by Gramnegative rods, anaerobic bacteria or unusual pathogens Subject has an infection that is expected to require other antifungal, antimycobacterial, or antibacterial agents in addition to study medication Other protocolspecific eligibility criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>cSSSI</keyword>
	<keyword>complicated skin and skin structure infections</keyword>
	<keyword>acute bacterial skin and skin structure infections</keyword>
	<keyword>abscess</keyword>
	<keyword>cellulitis</keyword>
	<keyword>bacterial infections</keyword>
	<keyword>anti-bacterial agents</keyword>
	<keyword>anti-infective agents</keyword>
	<keyword>skin diseases, infectious</keyword>
	<keyword>skin diseases</keyword>
	<keyword>wound infection</keyword>
</DOC>